Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03277378 · ClinicalTrials.gov registry record · NA
Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therapy During the Trial
A NA study of Chronic, Intractable Pain of the Trunk and/or Lower Limbs, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 270
- Enrollment target
- 20
- Study locations
NCT03277378 is a NA study of Chronic, Intractable Pain of the Trunk and/or Lower Limbs that has completed, run by Abbott Medical Devices. The registered enrollment target is 270 participants. The trial reports 20 study locations across 10 states.
The verdict
NCT03277378, a NA study of Chronic, Intractable Pain of the Trunk and/or Lower Limbs, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
- 20
- Study locations
Study Summary
Prospective, multi-center, randomized, single blind study
Conditions Studied
Interventions
- DEVICE lead placement followed by BurstDR stimulation
Study Locations (20)
Other
- Frankston Pain Management - Frankston
- North Shore Private Hospital - Saint Leonards
- Hospital Elisabethinen GmbH - Graz
- Wilhelminenspital Wien - Vienna
- Sana Kliniken Duisburg Gm.bH - Duisburg
- Medizinische Einrichtungen der Universität Düsseldorf - Düsseldorf
- Hospital Gera -Zentrum für interdisziplinäre Schmerztherapie - Gera
Florida
- Comprehensive Spine Institute - Clearwater
- Florida Pain Institute - Merritt Island
- National Pain Institute Winter Park - Winter Park
Nevada
- Advanced Pain Care - Las Vegas
- Nevada Advanced Pain Specialists - Reno
Oregon
- Oregon Health & Science University - Portland
- Spinal Diagnostics - Tualatin
California
- Jason Edward Pope, MD - Santa Rosa
Illinois
- Rush University - Chicago
Kansas
- Kansas University Medical Center - Kansas City
Rhode Island
- Rhode Island Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2017-09-22 |
| Est. Completion | 2018-10-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03277378
The ClinicalTrials.gov registry entry for NCT03277378 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic, Intractable Pain of the Trunk and/or Lower Limbs appearing as the primary indexed condition, and to 1 intervention - of which lead placement followed by BurstDR stimulation is the first listed.
NCT03277378 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Other, Florida, Nevada.
Frequently Asked Questions
What is clinical trial NCT03277378 about?
NCT03277378 is a clinical study titled "Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therapy During the Trial". Prospective, multi-center, randomized, single blind study
What is the current status of trial NCT03277378?
This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2017-09-22. Estimated completion is 2018-10-12.
What conditions does trial NCT03277378 study?
This clinical trial studies the following conditions: Chronic, Intractable Pain of the Trunk and/or Lower Limbs.
What interventions are being tested in trial NCT03277378?
The interventions under investigation include: lead placement followed by BurstDR stimulation (DEVICE).
Who is sponsoring clinical trial NCT03277378?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03277378 being conducted?
This trial has 20 study locations across California, Florida, Illinois, Kansas, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.